A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
Cervical cancer, one of the most common types of cancers, is mostly caused by HPV. Oncologist shares details on HPV and cervical cancer. Cervical cancer is one of the most common types of cancers ...